CVR: 44689790
Alveus Therapeutics ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Rajkumar Kannan. The company is owned by Alveus Therapeutics Inc., FPCI BioDiscovery 7 and Jeito II S.L.P. In 2025, the company reported a gross profit of DKK 22,056,673 and a net result of DKK 2,096,582 compared with DKK -5,608,478 the year before. Equity amounted to DKK 59,681,194.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed med forskning og eksperimentel udvikling indenfor bioteknologi.
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 1.053 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Alveus Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK 22,056,673, and the net result was DKK 2,096,582.
As of February 23, 2026, is registered as an owner of Alveus Therapeutics ApS with an ownership share of 5%.
As of January 23, 2026, is registered as an owner of Alveus Therapeutics ApS with an ownership share of 66%.
As of December 22, 2025, is registered as an owner of Alveus Therapeutics ApS with an ownership share of 5%.
As of November 15, 2025, Erik Voorspoels has stepped down as director of Alveus Therapeutics ApS.
As of September 22, 2025, Erik Voorspoels is registered as director of Alveus Therapeutics ApS.
As of September 22, 2025, Marie Louise Lindegaard has stepped down as director of Alveus Therapeutics ApS.
Alveus Therapeutics ApS has published its interim report for the period March 5, 2024 – December 31, 2024.
As of April 30, 2025, Rajkumar Kannan is registered as adm. dir. of Alveus Therapeutics ApS.
As of April 30, 2025, Nayan Gregory Parekh has stepped down as adm. dir. of Alveus Therapeutics ApS.
As of December 11, 2024, Marie Louise Lindegaard is registered as director of Alveus Therapeutics ApS.
As of December 11, 2024, Lars Peter Brunse has stepped down as director of Alveus Therapeutics ApS.
As of March 5, 2024, Lars Peter Brunse is registered as director of Alveus Therapeutics ApS.
As of March 5, 2024, Nayan Gregory Parekh is registered as adm. dir. of Alveus Therapeutics ApS.
Alveus Therapeutics ApS was founded on March 5, 2024.
Companies in the same industry and area
CVR 45506983
CVR 44695065
CVR 29418888
CVR 29769796
CVR 34892970
companydata.dk